 SAN DIEGO, March 23, 2022 GLOBE NEWSWIRE -- TRACON Pharmaceuticals NASDAQ: TCON, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat hosted by Jason McCarthy, at the Maxim Group 2022 Virtual Growth Conference on Wednesday, March 30, 2022 at 1:30pm Eastern Time. 